FACTOR XA INHIBITOR
Clinical trials for FACTOR XA INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new FACTOR XA INHIBITOR trials appear
Sign up with your email to follow new studies for FACTOR XA INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug studied to reverse blood thinners during emergency bleeding
Disease control Recruiting nowThis study tracks the safety and effectiveness of Ondexxya, a drug that reverses the effects of certain blood thinners (apixaban, rivaroxaban, or edoxaban) during life-threatening or unstoppable bleeding. Researchers will monitor 300 patients for side effects and how well the dru…
Matched conditions: FACTOR XA INHIBITOR
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could stroke patients on blood thinners finally get clot-busting treatment?
Disease control Recruiting nowThis study tests whether clot-busting drugs (alteplase or tenecteplase) are safe and effective for stroke patients who have taken a blood thinner (FXa inhibitor) in the last 48 hours. Current guidelines avoid this treatment due to bleeding concerns, but new evidence suggests it m…
Matched conditions: FACTOR XA INHIBITOR
Phase: PHASE3 • Sponsor: Guri Hagberg • Aim: Disease control
Last updated Jun 26, 2026 13:12 UTC